© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 9, 801-802,
May 5, 1999
© 1999 Oxford University Press
CORRESPONDENCE |
Re: Race, Prostate Cancer Survival, and Membership in a Large Health Maintenance Organization
Affiliation of authors: Department of Radiation Oncology, University of California, San Francisco.
Correspondence to: Mack Roach III, M.D., Department of Radiation Oncology, University of California, San Francisco, 505 Parnassus Ave., L-34, San Francisco, CA 94143-0226.
We believe that the article by Robbins et al. (1) was generated with good intentions; however, this study does a disservice in improving our understanding of the relationship between prostate cancer and race. The authors made numerous assumptions that require commentary.
First, cancer researchers do not decide that hormonal therapy or chemotherapy prolongs
survival in prostate cancer, breast cancer, or any other cancer on the basis of large
population-based studies (2). The U.S. Food and Drug Administration
approval for the use of a new drug is not based on large, crude, population-based studies. If the
sample
REFERENCES